Horizant and Ultrasound kidney abnormal - a phase IV clinical study of FDA data


We study 2,179 people who take Horizant or have Ultrasound kidney abnormal. No report of Ultrasound kidney abnormal is found in people who take Horizant.

The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 28, 2022

No report is found.

What is Horizant?

Horizant has active ingredients of gabapentin enacarbil. It is often used in restless leg syndrome. eHealthMe is studying from 1,886 Horizant users for its effectiveness, alternative drugs and more.

What is Ultrasound Kidney Abnormal?

Ultrasound kidney abnormal is found to be associated with 473 drugs and 207 conditions by eHealthMe.

Do you take Horizant and have Ultrasound kidney abnormal?

Check whether Ultrasound kidney abnormal is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Ultrasound kidney abnormal and when was it recovered:

Expand to all the drugs that have ingredients of gabapentin enacarbil:

Alternative drugs to, pros and cons of Horizant:

Ultrasound kidney abnormal treatments and more:

COVID vaccines that are related to Ultrasound kidney abnormal:

All the drugs that are associated with Ultrasound kidney abnormal:

All the conditions that are associated with Ultrasound kidney abnormal:

How the study uses the data?

The study uses data from the FDA. It is based on gabapentin enacarbil (the active ingredients of Horizant) and Horizant (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: